Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Exercise Intolerance in Cystic Fibrosis
NCT04039087Phase 3Completed
- Sponsor
- National Jewish Health
- Start
- Sep 2019
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in cystic fibrosis (CF), sponsored by National Jewish Health. Started Sep 2019; status: completed.
02
Drugs
ASP-001
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04039087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039087.